Antivirals for systemic use

Summary

The tender concerns a framework agreement for antivirals for systemic use, antibiotics, immunoglobulins, vaccines and serums. The framework agreements will be valid for 12 months from award. The notice also mentions a unilateral termination clause without compensation if new centralised framework agreements are concluded by the Ministry of Health, and a possible clause for revising or supplementing quantities if estimated quantities are not used up or are exceeded.